Here's some good news about the use of those strange things Monoclonal Antibodies which seem to be the focus of some attention. Its merely a lab based study though its encouraging that tigatuzumab (DR5) seems to making an impact on Pancreatic Cancer by helping to control re-growth of cells ( cancer stem cell control)
http://www.ncbi.nlm.nih.gov/pubmed/2066 ... t=Abstract
The work seems to be based in John Hopkins (USA) though also involves Spannish contributions which is also encouraging.
This forum contains news that Pancreatic Cancer UK and forum users have shared over the years.
1 post • Page 1 of 1